在逐渐减少eculizumab的剂量时,应考虑到其药理动学的非线性
Olivier Le Tilly1,2, Philippe Gatault1,3, Saida Semlali2
1Inserm U1327 ISCHEMIA "Membrane signalling and inflammation in reperfusion injuries", Université de Tours, Tours, France.
埃奎利祖马布表现出非线性药理动力学,这意味着其消除率随着度的变化而变化. 考虑到这种目标介导的消除对于优化脏疾病中的eculizumab剂量至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學.
- 免疫学 免疫学 免疫学
背景情况:
- 埃奎利祖马布是一种C5补充抑制剂,用于治疗脏疾病,如非典型的血溶性尿素性综合征和C3球体病变.
- 标准剂量可能导致药物度过高,引起人们对治疗药物监测的兴趣,以降低成本和优化疗效.
- 了解eculizumab的排泄途径是制定个性化剂量策略的关键.
研究的目的:
- 为了研究eculizumab的目标介导消除.
- 为了比较非线性药理动力学模型对eculizumab度的线性模型的预测准确度.
- 在病患者中为eculizumab量身定制的剂量方案提供信息.
主要方法:
- 从44名患者中对377个eculizumab血清度进行了群体药理动力学分析.
- 计算临界度以评估目标介导消除的意义.
- 模拟剂量方案,以预测达到目标最低度 (>100 mg/L) 的概率.
主要成果:
- 埃奎利祖马布表现出非线性药理动力学,包括第一阶和迈凯利斯-门消除成分.
- 清除量和分布量依赖于体重,在治疗度时明显的非线性.
- 模拟表明,每21天服用1200毫克的疗法可以在85% (50kg) 和76% (90kg) 的患者中维持治疗暴露.
结论:
- 埃奎利祖马布的排泄是非线性的,受到目标介导过程的影响.
- 将目标介导清除纳入药理动力学模型可以改善eculizumab度的预测.
- 考虑到非线性消除的治疗药物监测对于优化脏疾病中的eculizumab治疗很重要.
更多相关视频
11:39The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Nonlinear Pharmacokinetics: Overview
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
Nonlinear Pharmacokinetics: Causes of Nonlinearity
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...
